The outcomes from the Western blotting analysis indicated a marked elevation in HRS levels upon either EGFR mutation or EGF stimulation in NSCLC cells, whereas levels of RAB27a and ALIX remained unchanged (Figure 2H and Figure S4A–D). This evidence concerns the gene EGF and non-small cell lung carcinoma.